A comparative evaluation of serum and salivary levels of apelin in chronic periodontitis associated with obesity and type 2 diabetes mellitus

Panineeya institute of dental sciences and research centre0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients with BMI 30.0 â?? 39.0 kg/m2 for group 2. (Centers for Disease Control and Prevention)
•Patients previously diagnosed with T2DM and under medication were confirmed by their glycated haemoglobin (HbA1c: 6.5% - 8.5 --ADA,2017)
•Patients with at least 15 natural teeth remaining.
•Patients suffering from chronic periodontitis (>= 5mm pocket depth or >= 3mm loss of attachment) were selected. (Update to 1999 Disease Classification-AAP)
•Patients who have not received periodontal therapy, within preceding six months.

•Patients having aggressive periodontitis.
•Patients having any other systemic diseases.
•Patients with BMI > 40 kg/m2.
•Patients with HbA1c > 8.5%.
•Patients taking high-dose steroid therapy, radiation or immunosuppressive therapy.
•Pregnant and lactating woman.
•History of smoking within the past five years.
•Mentally retarded and un-cooperative patients

发起方

Panineeya institute of dental sciences and research centre